Bioinformatics Market to Reach $34.41 Billion by 2031, Fueled by AI Integration and Growth in Precision Medicine

Bioinformatics Market by Offerings (Software (Genomics, Multiomics, Proteomics), Services (Analysis, Sequencing)), Function (Variant & Structural Analysis), Use Case (Drug Discovery, Biomarker), End User (Pharma & Biotech, CROs) - Global Forecast to 2031
According to MarketsandMarkets Trademark , The global bioinformatics market [https://www.marketsandmarkets.com/Market-Reports/bioinformatics-39.html?utm_source=abnewswire.com&utm_medium=referral&utm_campaign=paidpr] is projected to grow from USD 18.63 billion in 2026 to USD 34.41 billion by 2031, at a CAGR of 13.1% during the forecast period. Market growth is being driven by the rapid integration of artificial intelligence (AI), machine learning (ML), and cloud computing into bioinformatics workflows, enabling faster, more accurate, and scalable analysis of complex biological data.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=39 [https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=39&utm_source=abnewswire.com&utm_medium=referral&utm_campaign=paidpr]

The increasing adoption of next-generation sequencing (NGS) technologies and the rising demand for precision medicine are significantly boosting the need for advanced bioinformatics solutions. Cloud-based platforms are further supporting market expansion by enabling secure data storage, scalable computing resources, and real-time collaboration across research institutions, healthcare providers, and pharmaceutical companies.

Multi-Omics Integration Segment to Register Fastest Growth

By function, the multi-omics integration segment is expected to register the highest growth during the forecast period. This growth is driven by the increasing use of genomics, proteomics, and metabolomics in precision medicine, biomarker discovery, and drug development.

The growing availability of high-throughput biological data is creating demand for advanced tools capable of integrating and analyzing multidimensional datasets. The use of AI and ML in multi-omics research is enhancing data interpretation, predictive modeling, and analytics, accelerating discoveries in areas such as cancer genomics, rare diseases, immunology, and systems biology.

Pharmaceutical & Biotechnology Companies Lead Market Demand

By end user, pharmaceutical and biotechnology companies accounted for the largest share of the bioinformatics market in 2025. This dominance is attributed to the increasing application of bioinformatics in drug discovery and development processes, including target identification, molecular modeling, and lead optimization.

The shift toward precision medicine and personalized therapies is further driving the adoption of bioinformatics tools. Additionally, growing investments in computational biology, AI, and advanced analytics are enabling more efficient virtual screening, predictive modeling, and therapeutic development.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=39 [https://www.marketsandmarkets.com/requestsampleNew.asp?id=39&utm_source=abnewswire.com&utm_medium=referral&utm_campaign=paidpr]

Asia Pacific Emerges as Fastest-Growing Region

The Asia Pacific region is expected to register the highest growth rate during the forecast period. Growth in this region is driven by increasing adoption of NGS technologies, rising investments in genomics research, and expanding biotechnology and pharmaceutical sectors.

Countries such as China, India, Japan, South Korea, and Singapore are actively investing in healthcare infrastructure, digital health technologies, and AI-based research platforms. The region's large patient population and increasing prevalence of chronic diseases are further creating demand for advanced bioinformatics solutions.

North America continues to hold a significant market share, supported by strong research infrastructure, high adoption of advanced technologies, and the presence of leading market players.

Competitive Landscape

Key players in the bioinformatics market include Thermo Fisher Scientific Inc. (US), Illumina, Inc. (US), QIAGEN N.V. (Netherlands), Agilent Technologies, Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), Revvity, Inc. (US), Eurofins Scientific (Luxembourg), BGI Genomics (China), Waters Corporation (US), DNAnexus, Inc. (US), Oxford Nanopore Technologies plc (UK), 10x Genomics (US), Pacific Biosciences (PacBio) (US), Dotmatics (US), and SOPHiA GENETICS (US).

These companies are focusing on innovation, strategic collaborations, and expanding their bioinformatics platforms to address the growing demand for advanced data analytics and precision healthcare solutions.

Related Reports:

Next-generation Sequencing Market [https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=546&utm_source=abnewswire.com&utm_medium=referral&utm_campaign=paidpr] - Global Forecast to 2031

Genomics Market [https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=613&utm_source=abnewswire.com&utm_medium=referral&utm_campaign=paidpr] - Global Forecast to 2030

Media Contact
Company Name: MarketsandMarkets Trademark Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=bioinformatics-market-to-reach-3441-billion-by-2031-fueled-by-ai-integration-and-growth-in-precision-medicine]
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Florida
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/bioinformatics-39.html

Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com



This release was published on openPR.